Antihypertensive medication in frail older adults: A narrative review through a deprescribing lens
Related Experiment Video
Updated: Jun 29, 2025

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Roni Kraut1, Carina Lundby2,3,4, Oksana Babenko1
1Department of Family Medicine, University of Alberta, Edmonton, Canada.
Purpose Of Review:
The management of hypertension in frail older adults remains controversial, as these patients are underrepresented in clinical trials and practice guidelines. Overtreatment may cause harm while undertreatment may lead to greater risk of cardiovascular events. Our research aims to examine this controversy and provide guidance regarding deprescribing decisions in frail older adults.
Results:
Current evidence suggests that there may be minimal cardiovascular benefit and significant harm of antihypertensive medication in the frail older adult population. A minority of hypertension guidelines provide sufficient recommendations for frail older adults, and there are limited tools available to guide clinical decision-making.
Conclusion:
Randomized controlled trials and well-designed observational studies are needed to confirm the benefit-to-harm relationship of antihypertensive medication in frail older adults. Decision tools that comprehensively address antihypertensive deprescribing would be advantageous to help clinicians with hypertension management in this population. Clinicians should engage in shared decision-making with the patient and family to ensure that decisions regarding antihypertensive deprescribing best meet the needs of all involved.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Therapy
Antianxiety Medications
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Antidepressant Drugs: MAOIs and Other Agents
Antihypertensive Drugs: Vasodilators

